More on KALA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+45.9% Growth)
- Ratings (4.5 Score)
- FDA Archive

Upcoming Events

- Earnings (11/10/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

KALA BIO (NQ:KALA)
Delayed: 3.61 +0.76 (26.67%)
Prev. Close $2.85  
Open$2.85 
52 Wk High$ 
52 Wk Low$ 
Day High$3.66 
Day Low$2.85 
P/E N/A  
EPS$ 
Volume959,166 

Friends, Peers and Foes (?): CYN DOMO (more...)

Jun 12, 2026 04:06 PM Form S-3/A KALA BIO, Inc.
May 15, 2026 04:26 PM Form SCHEDULE 13G/A KALA BIO, Inc. Filed by: BAKER BROS. ADVISORS LP
May 15, 2026 03:31 PM Form 10-Q KALA BIO, Inc. For: Mar 31
May 7, 2026 05:25 PM Form S-3 KALA BIO, Inc.
May 7, 2026 04:09 PM Form 8-K KALA BIO, Inc. For: May 07
May 7, 2026 09:00 AM KALA BIO implements 1-for-50 reverse stock split effective May 8
May 7, 2026 09:00 AM KALA BIO Announces Reverse Stock Split
Apr 28, 2026 08:00 AM Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
Apr 21, 2026 07:00 AM Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
Apr 15, 2026 04:04 PM Form 10-K KALA BIO, Inc. For: Dec 31
View All Articles

Entities mentioned with KALA

View All Entities